146 related articles for article (PubMed ID: 1095081)
1. Comparative symptomatological and evoked potential studies with d-amphetamine, thioridazine, and placebo in hyperkinetic children.
Saletu B; Saletu M; Simeon J; Viamontes G; Itil TM
Biol Psychiatry; 1975 Jun; 10(3):253-75. PubMed ID: 1095081
[TBL] [Abstract][Full Text] [Related]
2. D-amphetamine and delinquency: hyperkinesis persisting?
Maletzky BM
Dis Nerv Syst; 1974 Dec; 35(12):543-7. PubMed ID: 17896753
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of methylphenidate and thioridazine in hyperkinetic children. I. Clinical results.
Gittelman-Klein R; Klein DF; Katz S; Saraf K; Pollack E
Arch Gen Psychiatry; 1976 Oct; 33(10):1217-31. PubMed ID: 971031
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
5. Effect of thioridazine, amphetamine and placebo on the hyperkinetic syndrome and cognitive area in mentally deficient children.
Alexandris A; Lundell FW
Can Med Assoc J; 1968 Jan; 98(2):92-6. PubMed ID: 4864657
[No Abstract] [Full Text] [Related]
6. A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction.
Gross MD
Dis Nerv Syst; 1976 Jan; 37(1):14-6. PubMed ID: 1106966
[TBL] [Abstract][Full Text] [Related]
7. Methylphenidate in hyperkinetic children: differences in dose effects on impulsive behavior.
Brown RT; Sleator EK
Pediatrics; 1979 Oct; 64(4):408-11. PubMed ID: 492804
[TBL] [Abstract][Full Text] [Related]
8. Relative effects of drugs and diet on hyperactive behaviors: an experimental study.
Williams JI; Cram DM; Tausig FT; Webster E
Pediatrics; 1978 Jun; 61(6):811-7. PubMed ID: 353680
[TBL] [Abstract][Full Text] [Related]
9. Multicenter study comparing thioridazine with diazepam and placebo in elderly, nonpsychotic patients with emotional and behavioral disorders.
Stotsky B
Clin Ther; 1984; 6(4):546-59. PubMed ID: 6380725
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder.
Bilici M; Yildirim F; Kandil S; Bekaroğlu M; Yildirmiş S; Değer O; Ulgen M; Yildiran A; Aksu H
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):181-90. PubMed ID: 14687872
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
[TBL] [Abstract][Full Text] [Related]
13. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
14. The evoked potential in pharmacopsychiatry.
Saletu B
Neuropsychobiology; 1977; 3(2-3):75-104. PubMed ID: 896005
[TBL] [Abstract][Full Text] [Related]
15. Thioridazine in the treatment of depressive patients.
de Jonghe FE; Schalken HF; van der Helm HJ
Acta Psychiatr Scand; 1976 Apr; 53(4):271-6. PubMed ID: 775889
[TBL] [Abstract][Full Text] [Related]
16. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
Research Units on Pediatric Psychopharmacology Autism Network
Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
[TBL] [Abstract][Full Text] [Related]
17. Clonidine treatment of hyperactive and impulsive children with autistic disorder.
Jaselskis CA; Cook EH; Fletcher KE; Leventhal BL
J Clin Psychopharmacol; 1992 Oct; 12(5):322-7. PubMed ID: 1479049
[TBL] [Abstract][Full Text] [Related]
18. Effects of thioridazine dosage on the behavior of severely mentally retarded persons.
Singh NN; Aman MG
Am J Ment Defic; 1981 May; 85(6):580-7. PubMed ID: 7023237
[TBL] [Abstract][Full Text] [Related]
19. The effects of methylphenidate on the soft neurological signs of hyperactive children.
Lerer RJ; Lerer MP
Pediatrics; 1976 Apr; 57(4):521-5. PubMed ID: 772581
[TBL] [Abstract][Full Text] [Related]
20. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
Biederman J; Pliszka SR
J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
